THE ORIGIN OF HODGKIN AND REED/STERNBERG CELLS IN HODGKIN'S DISEASE
One of the characteristic features of Hodgkin's disease (HD) is the presence of a small population of often bizarre-looking large mono- or multinucleated Hodgkin and Reed-Sternberg (HRS) cells within the affected tissue. Recent cytogenetic investigations, studies of Epstein-Barr virus (EBV) gen...
Gespeichert in:
Veröffentlicht in: | Annual review of immunology 1998-01, Vol.16 (1), p.471-493 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | One of the characteristic features of Hodgkin's disease (HD) is the
presence of a small population of often bizarre-looking large mono- or
multinucleated Hodgkin and Reed-Sternberg (HRS) cells within the affected
tissue. Recent cytogenetic investigations, studies of Epstein-Barr virus (EBV)
genomes present in HRS cells, and analyses of Ig gene rearrangements amplified
from single, micromanipulated HRS cells show that these cells largely represent
clonal populations. The finding of Ig gene rearrangements in HRS cells in most
cases of HD identifies B cells as the precursors of HRS cells in most if not
all cases. Furthermore, the presence and pattern of somatic mutations within
the rearranged Ig genes show that HRS cells in classical (i.e. nodular
sclerosis, mixed cellularity, and lymphocyte depletion HD) as well as
lymphocyte predominant (LP) HD originate from germinal center (GC) B cells.
Ongoing somatic mutation and evidence for selection link HRS cells from LP HD
to a mutating, antigen-selected GC B cell. In classical HD, the finding of
"crippling" mutations and lack of stringent selection for antigen
receptor expression suggests that in this case HRS cells are derived from a
compartment of GC B cells that were destined to die but escaped apoptosis by
some transforming event. One candidate for the latter is EBV infection. |
---|---|
ISSN: | 0732-0582 1545-3278 |
DOI: | 10.1146/annurev.immunol.16.1.471 |